HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer Detection and Diagnosis

  • Imaging and Radiology: Advances in MRI, CT, PET scans, and AI in imaging.
  • Pathology and Histopathology: Role of molecular diagnostics and digital pathology.
  • Genetic Testing and Biomarkers: Use of genetic profiling in risk assessment and targeted therapy.
  • Screening Programs: Population-based screening, early detection methods, and public health implications.
  • Liquid Biopsies: Emerging non-invasive methods for early detection and monitoring.

Detecting and diagnosing cancer early is vital for successful treatment and improved survival rates. Modern techniques like MRI, CT, and PET scans allow doctors to identify abnormalities at very early stages. Non-invasive methods, such as liquid biopsies, are gaining prominence by detecting cancer biomarkers in blood samples. Artificial intelligence is also making strides in cancer care, offering deeper insights by analyzing imaging and genetic data with exceptional accuracy. These innovations enable tailored treatment plans, enhancing the effectiveness of therapies. Ongoing research continues to drive progress, offering hope for more precise and accessible cancer diagnosis worldwide.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp